tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Venture Life Buys Back 49,475 Shares for Treasury Under Ongoing Programme

Story Highlights
  • Venture Life repurchased 49,475 ordinary shares at 66.98 pence, holding them in treasury.
  • The buyback leaves 125.8 million voting shares, marginally increasing existing investors’ relative stakes.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Venture Life Buys Back 49,475 Shares for Treasury Under Ongoing Programme

Claim 50% Off TipRanks Premium

The latest announcement is out from Venture Life ( (GB:VLG) ).

Venture Life Group has repurchased 49,475 of its own ordinary shares at a volume-weighted average price of 66.98 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,737,145 ordinary shares in issue, of which 2,913,893 are held in treasury, leaving 125,823,252 voting shares in circulation, a change that may affect shareholder calculations for regulatory disclosure thresholds and slightly consolidates existing investors’ relative stakes.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on GB:VLG Stock

According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.

Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.

To see Spark’s full report on GB:VLG stock, click here.

More about Venture Life

Venture Life Group is a UK-headquartered international consumer self-care company focused on the global self-care market. Its portfolio spans women’s intimate healthcare (Balance Activ), ENT care (Earol), energy and glucose management and hypoglycaemia (Lift and Glucogel), and the Health & Her range for the hormonal lifecycle, with products typically recommended by pharmacists and healthcare practitioners and sold through retail and e-commerce channels worldwide, either directly or via international distribution partners.

Average Trading Volume: 195,336

Technical Sentiment Signal: Buy

Current Market Cap: £84.75M

Find detailed analytics on VLG stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1